Clinical Trial Update: Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial assessing safety and tolerability of Antimicrobial TheraGauze for skin abscess due to furunculosis has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Furunculosis

Drugs mentioned

• Antimicrobial TheraGauze

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Furunculosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-08-29